ArticleBMJ mental health2025

Use of GLP-1 receptor agonists and risks of suicide attempts or self-harm in patients with type 2 diabetes: a multicountry self-control case series study.

Zi-Yang Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.